Condition
Legius Syndrome
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting3
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07005297Not Yet Recruiting
Clinical Genetics Branch Eligibility Screening Survey
NCT00111384Completed
Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
NCT04888936Recruiting
Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies
NCT05361811Not ApplicableRecruiting
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
NCT04395495Recruiting
RASopathy Biorepository
Showing all 5 trials